|
药物联合rTMS对帕金森病临床症状及血清学指标改善的Meta分析
|
Abstract:
目的:针对药物联合rTMS治疗帕金森病的临床疗效进行文献Meta分析,为优化帕金森病治疗方案提供数据支持。方法:检索英文及中文数据库,收集rTMS联合药物治疗PD临床效果的相关文献,采集核心数据,进行Meta分析。结果:与单纯普拉克索组相比,rTMS联合普拉克索治疗PD后患者精神行为情绪[WMD = ?0.37, 95% CI = (?0.47, ?0.26)],日常生活活动能力[WMD = ?1.43, 95% CI = (?2.15, ?0.70)],运动功能[WMD = ?2.13, 95% CI = (?2.74, ?1.51)],抑郁评分[WMD = ?2.31, 95% CI = (?2.84, ?1.78)],简易智能精神状态[WMD = 2.23, 95%CI = (1.91, 2.54)]均得到改善,且两组间存在统计学差异(p < 0.05)。氧化应激反应指标均降低,Cys-C [WMD = ?0.25, 95% CI = (?0.31, ?0.19)]、NES [WMD = ?2.75, 95% CI = (?3.50, ?2.00)]、S100B [WMD = ?4.88, 95% CI = (?6.03, ?3.74)],两组间存在统计学意义(p < 0.05)。与单纯多巴丝肼组相比,rTMS联合多巴丝肼治疗PD后患者精神行为情绪[WMD = ?2.13, 95% CI = (?2.99, ?1.27)],日常生活活动能力[WMD = ?6.11, 95% CI = (?7.05, ?5.16)],运动功能[WMD = ?4.87, 95%CI = (?6.05, ?3.69)],自主神经症状[WMD = ?6.85, 95% CI = (?7.96, ?5.74)]均得到改善,且两组间存在统计学差异(p < 0.05)。神经递质水平得到改善,乙酰胆碱[WMD = ?2.74, 95% CI = (?4.05, ?1.44)]、多巴胺[WMD = 13.81, 95% CI = (11.02, 16.61)],两组间存在统计学意义(p < 0.05)。结论:rTMS联合药物治疗可有效改善PD患者临床疗效,并对血清氧化应激及神经递质水平也存在调整作用。
Objective: To conduct a literature Meta-analysis on the clinical efficacy of drug combined with rTMS in the treatment of Parkinson’s disease, providing data support for optimizing the treatment plan of Parkinson’s disease. Method: Retrieve English and Chinese databases, collect relevant literature on the clinical efficacy of rTMS combined with drug therapy for PD, collect core data, and conduct Meta-analysis. Result: Compared with the Pramipexole alone group, patients with Parkinson’s disease treated with the combination of rTMS and Pramipexole had psychology, behavior and emotional [WMD = ?0.37, 95% CI = (?0.47, ?0.26)], activities of daily living [WMD = ?1.43, 95% CI = (?2.15, ?0.70)], motor function [WMD = ?2.13, 95% CI = (?2.74, ?1.51)], depression score [WMD = ?2.31, 95% CI = (?2.84, ?1.78)], and simplified mental state [WMD = 2.23, 95% CI = (1.91, 2.54)] showed varying degress of improvement, and there was a statistical difference between the two groups (p < 0.05). The oxidative stress response indicators were all reduced, with Cys-C [WMD = ?0.25, 95% CI = (?0.31, ?0.19)], NES
[1] | 张敏, 农金梅, 韦人瑜, 等. 低频和高频重复经颅磁刺激对帕金森病流涎患者的影响[J]. 中国实用医药, 2023, 18(20): 59-62. |
[2] | 廖珍珍, 袁良津, 唐向阳, 等. 高频重复经颅磁刺激对早期帕金森病轻度认知功能障碍的疗效观察[J]. 临床神经病学杂志, 2021, 34(1): 32-36. |
[3] | Li, S., Jiao, R., Zhou, X. and Chen, S. (2020) Motor Recovery and Antidepressant Effects of Repetitive Transcranial Magnetic Stimulation on Parkinson Disease: A PRISMA-Compliant Meta-Analysis. Medicine, 99, e19642. https://doi.org/10.1097/md.0000000000019642 |
[4] | Chen, J., He, P., Zhang, Y., et al. (2020) Non-Pharmacological Treatment for Parkinson Disease Patients with Depression: A Meta-Analysis of Repetitive Transcranial Magnetic Stimulation and Cognitive-Behavioral Treatment. International Journal of Neuroscience, 131, 411-424. https://doi.org/10.1080/00207454.2020.1744591 |
[5] | Khedr, E.M., Mohamed, K.O., Ali, A.M. and Hasan, A.M. (2019) The Effect of Repetitive Transcranial Magnetic Stimulation on Cognitive Impairment in Parkinson’s Disease with Dementia: Pilot Study. Restorative Neurology and Neuroscience, 38, 55-66. https://doi.org/10.3233/rnn-190956 |
[6] | Wang, X., Dong, T., Li, X., Yu, W., Jia, Z., Liu, Y., et al. (2024) Global Biomarker Trends in Parkinson’s Disease Research: A Bibliometric Analysis. Heliyon, 10, e27437. https://doi.org/10.1016/j.heliyon.2024.e27437 |
[7] | 乔宏泉. 低频重复经颅磁刺激联合普拉克索治疗帕金森病的疗效观察[J]. 医药论坛杂志, 2020, 41(5):145-147. |
[8] | 吕春翔. 高频与低频重复经颅磁刺激治疗帕金森病的临床观察[J]. 中国医疗器械信息, 2015, 21(2): 73. |
[9] | 吴薇薇. 盐酸普拉克索联合美多巴治疗帕金森病的临床研究[J]. 南通大学学报(医学版), 2017, 37(2): 162-163. |
[10] | Yang, Y., Gao, F., Gao, L. and Miao, J. (2023) Effects of Rasagiline Combined with Levodopa and Benserazide Hydrochloride on Motor Function and Homocysteine and IGF-1 Levels in Elderly Patients with Parkinson’s Disease. BMC Neurology, 23, Article No. 360. https://doi.org/10.1186/s12883-023-03411-3 |
[11] | Begemann, M.J., Brand, B.A., Ćurčić-Blake, B., Aleman, A. and Sommer, I.E. (2020) Efficacy of Non-Invasive Brain Stimulation on Cognitive Functioning in Brain Disorders: A Meta-Analysis. Psychological Medicine, 50, 2465-2486. https://doi.org/10.1017/s0033291720003670 |
[12] | 郭芬. 高频重复经颅磁刺激在帕金森病患者中的应用效果观察[J]. 医药论坛杂志, 2020, 41(4): 98-101. |
[13] | Pereira, A.P.S., Marinho, V., Gupta, D., Magalhães, F., Ayres, C. and Teixeira, S. (2018) Music Therapy and Dance as Gait Rehabilitation in Patients with Parkinson Disease: A Review of Evidence. Journal of Geriatric Psychiatry and Neurology, 32, 49-56. https://doi.org/10.1177/0891988718819858 |
[14] | Dragašević-Mišković, N., Petrović, I., Stanković, I. and Kostić, V.S. (2018) Chemical Management of Levodopa-Induced Dyskinesia in Parkinson’s Disease Patients. Expert Opinion on Pharmacotherapy, 20, 219-230. https://doi.org/10.1080/14656566.2018.1543407 |
[15] | Erkkinen, M.G., Kim, M. and Geschwind, M.D. (2017) Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harbor Perspectives in Biology, 10, a033118. https://doi.org/10.1101/cshperspect.a033118 |
[16] | Salinas, F.S., Lancaster, J.L. and Fox, P.T. (2007) Detailed 3D Models of the Induced Electric Field of Transcranial Magnetic Stimulation Coils. Physics in Medicine and Biology, 52, 2879-2892. https://doi.org/10.1088/0031-9155/52/10/016 |
[17] | Wong, P., Yang, Y., Huang, S., Fuh, J., Chiang, H. and Wang, R. (2022) Transcranial Direct Current Stimulation on Different Targets to Modulate Cortical Activity and Dual-Task Walking in Individuals with Parkinson’s Disease: A Double Blinded Randomized Controlled Trial. Frontiers in Aging Neuroscience, 14, Article 807151. https://doi.org/10.3389/fnagi.2022.807151 |
[18] | 赵学飞. 重复经颅磁刺激治疗帕金森病临床效果的Meta分析[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2015. |
[19] | Ma, J., Gao, L., Mi, T., Sun, J., Chan, P. and Wu, T. (2019) Repetitive Transcranial Magnetic Stimulation Does Not Improve the Sequence Effect in Freezing of Gait. Parkinson’s Disease, 2019, Article 2196195. https://doi.org/10.1155/2019/2196195 |
[20] | 王煜姝, 马花, 张康. 高频重复经颅磁刺激治疗帕金森病认知功能障碍患者的临床效果[J]. 临床研究, 2024, 32(2): 82-85. |